Treatment of Acute Cough Due to the Common Cold: Multi-component, Multi-symptom Therapy is Preferable to Single-Component, Single-Symptom Therapy—A Pro/Con Debate

Ronald Eccles, Ronald B. Turner, Peter Vytautas Dicpinigaitis

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Acute viral upper respiratory tract infection, or, the common cold, affects essentially every human being, and cough is reported as its most frequent associated symptom. Billions of dollars are spent worldwide annually by individuals seeking relief from this multi-symptom syndrome. Thousands of non-prescription, over-the-counter products are available worldwide, aimed at relieving the various bothersome symptoms induced by the common cold. Differences of opinion exist as to whether optimal therapy for cough associated with the common cold consists of multi-component, multi-symptom cough/cold preparations, or, whether single-component medications, aimed at relief of specific symptoms, represent the optimal therapeutic approach. The 5th American Cough Conference, held in Washington, D.C. in June, 2015, provided an ideal forum for discussion and debate of this issue between two internationally recognized experts in the field of the common cold and its treatment.

Original languageEnglish (US)
Pages (from-to)15-20
Number of pages6
JournalLung
Volume194
Issue number1
DOIs
Publication statusPublished - Feb 1 2016

    Fingerprint

Keywords

  • Antitussive
  • Common cold
  • Cough
  • Respiratory tract infection
  • Viral infection

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this